Bowei Yang - Search Results

Year	Number of Results
2005	1
2014	1
2018	1
2020	3
2021	6
2022	7
2023	14
2024	3

1

An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity.

Wu T, Liu C, Zou S, Lyu R, Yang B, Yan H, Zhao M, Tang W. Wu T, et al. Among authors: yang b. Nat Chem Biol. 2023 Nov;19(11):1384-1393. doi: 10.1038/s41589-023-01380-9. Epub 2023 Jul 3. Nat Chem Biol. 2023. PMID: 37400536 Free PMC article.

2

Materials engineering strategies for cancer vaccine adjuvant development.

Zhang X, Yang B, Ni Q, Chen X. Zhang X, et al. Among authors: yang b. Chem Soc Rev. 2023 May 9;52(9):2886-2910. doi: 10.1039/d2cs00647b. Chem Soc Rev. 2023. PMID: 37014050 Review.

3

MOF-derived bimetallic nanozyme to catalyze ROS scavenging for protection of myocardial injury.

Xiang K, Wu H, Liu Y, Wang S, Li X, Yang B, Zhang Y, Ma L, Lu G, He L, Ni Q, Zhang L. Xiang K, et al. Among authors: yang b. Theranostics. 2023 Apr 29;13(8):2721-2733. doi: 10.7150/thno.83543. eCollection 2023. Theranostics. 2023. PMID: 37215581 Free PMC article.

4

Diagnostic and therapeutic value of biomarkers in urosepsis.

Wu Y, Wang G, Huang Z, Yang B, Yang T, Liu J, Li P, Li J. Wu Y, et al. Among authors: yang b. Ther Adv Urol. 2023 Jan 31;15:17562872231151852. doi: 10.1177/17562872231151852. eCollection 2023 Jan-Dec. Ther Adv Urol. 2023. PMID: 36744043 Free PMC article. Review.

5

Osteopontin: An important protein in the formation of kidney stones.

Jia Q, Huang Z, Wang G, Sun X, Wu Y, Yang B, Yang T, Liu J, Li P, Li J. Jia Q, et al. Among authors: yang b. Front Pharmacol. 2022 Nov 9;13:1036423. doi: 10.3389/fphar.2022.1036423. eCollection 2022. Front Pharmacol. 2022. PMID: 36452224 Free PMC article. Review.

6

Pathogenesis of Proteus mirabilis in Catheter-Associated Urinary Tract Infections.

Yuan F, Huang Z, Yang T, Wang G, Li P, Yang B, Li J. Yuan F, et al. Among authors: yang b. Urol Int. 2021;105(5-6):354-361. doi: 10.1159/000514097. Epub 2021 Mar 10. Urol Int. 2021. PMID: 33691318 Free article. Review.

7

Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity.

Yang L, Lang Y, Wu H, Xiang K, Wang Y, Yu M, Liu Y, Yang B, He L, Lu G, Ni Q, Chen X, Zhang L. Yang L, et al. Among authors: yang b. ACS Nano. 2023 Mar 28;17(6):5340-5353. doi: 10.1021/acsnano.2c08429. Epub 2023 Mar 13. ACS Nano. 2023. PMID: 36913671

8

Synergistic Glutathione Depletion and STING Activation to Potentiate Dendritic Cell Maturation and Cancer Vaccine Efficacy.

Liu J, Zhang Y, Yang B, Jia Y, Liu RT, Ding L, Shen Z, Chen X. Liu J, et al. Among authors: yang b. Angew Chem Int Ed Engl. 2024 Mar 4;63(10):e202318530. doi: 10.1002/anie.202318530. Epub 2024 Jan 23. Angew Chem Int Ed Engl. 2024. PMID: 38196070

9

Succinate Dehydrogenase Defects Giant Renal Cell Carcinoma.

Sun X, Wang G, Huang Z, Li P, Yang B, Wang T, Li J. Sun X, et al. Among authors: yang b. Urol Int. 2023;107(8):819-822. doi: 10.1159/000531059. Epub 2023 Jun 30. Urol Int. 2023. PMID: 37393904 Free PMC article.

10

Characterization of metabolism-associated molecular patterns in prostate cancer.

Yang B, Jiang Y, Yang J, Zhou W, Yang T, Zhang R, Xu J, Guo H. Yang B, et al. BMC Urol. 2023 Jun 6;23(1):104. doi: 10.1186/s12894-023-01275-w. BMC Urol. 2023. PMID: 37280589 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year